By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet To Present At Upcoming Conferences This Summer 7/1/2015 10:35:41 AM
Egalet Announces Top-Line Results From Oral Human Abuse Liability Study Of Egalet-002 6/30/2015 6:18:34 AM
Egalet Jumps As Lead Drug Is Less Likely To Be Abused Than Other Painkillers 6/29/2015 6:28:56 AM
Egalet's Abuse-Deterrent, Extended-Release Morphine Demonstrates Bioequivalence At 60 Mg Dose 6/25/2015 6:56:22 AM
Egalet Appoints Timothy P. Walbert As Chairman Of Board Of Directors 6/15/2015 7:24:16 AM
Egalet Release: In a Clinical Alcohol Interaction Study Egalet-002, An Abuse-Deterrent, Extended-Release Oxycodone Product Candidate, Did Not Induce Alcohol Dose Dumping -- An Important Attribute Given Alcohol Use Seen With Chronic Pain Patients 6/4/2015 6:30:01 AM
Egalet Category 1 Abuse-Deterrent Studies Demonstrated Strong Abuse-Deterrent Properties Of Egalet-002 Compared To Reformulated OxyContin 5/28/2015 6:32:14 AM
Egalet To Present At Upcoming Conferences In June 5/26/2015 6:56:28 AM
Egalet Announces Issuance Of U.S. Patents Covering Guardian Technology And Product Candidates 5/19/2015 6:24:47 AM
Egalet President And Chief Executive Officer Bob Radie Appointed To Pennsylvania Bio Board Of Directors 5/12/2015 6:32:56 AM